Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
No Comments.